The global distribution of biologics is undergoing a major overhaul in 2026 as demand for temperature-sensitive peptides reaches an all-time high. New "passive-cooling" technologies and IoT-enabled tracking systems are now mandatory for the transport of high-value insulin analogues and GLP-1 therapies. These advancements are particularly critical in tropical climates, where the transition from...
Russian 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Tiếng Việt